SCHEMBL10176327

SCHEMBL10176327

O=C(c1cccc(-c2cc3ccccc3n2S(=O)(=O)c2ccccc2)c1)c1cc2ccccc2n1-c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 4/20 0.51
HDAC4 P56524 4/20 0.51
HDAC1 Q13547 4/20 0.51
HDAC7 Q8WUI4 4/20 0.51
HDAC2 Q92769 4/20 0.51
HDAC10 Q969S8 4/20 0.51
HDAC11 Q96DB2 4/20 0.51
HDAC8 Q9BY41 4/20 0.51
HDAC6 Q9UBN7 4/20 0.51
HDAC9 Q9UKV0 4/20 0.51
HDAC5 Q9UQL6 4/20 0.51
CA12 O43570 3/20 0.50
CA9 Q16790 3/20 0.50
CA2 P00918 1/20 0.50
ACLY P53396 4/20 0.48
ALDH1A1 P00352 2/20 0.47
TSHR P16473 1/20 0.47
LMNA P02545 1/20 0.47
MAPT P10636 1/20 0.47
PLA2G10 O15496 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL424372 0.90 HDAC3 (0.60) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL10176177 0.89 CA12 (0.49) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL425798 0.87 CA12 (0.58) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL428130 0.81 ACLY (0.54) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL13790750 0.80 HDAC3 (0.46) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL426732 0.78 CA12 (0.49) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL423211 0.78 CA12 (0.49) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL424094 0.78 PDE4A (0.50) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL10226042 0.78 CA12 (0.48) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL10176318 0.77 CA12 (0.50) CA12CA9CA2ACLYALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120022121-A1 INDOLES, DERIVATIVES AND ANALOGS THEREOF AND USES THEREFOR NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2012-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120022121-A1 INDOLES, DERIVATIVES AND ANALOGS THEREOF AND USES THEREFOR TUBB, TUBB3, TUBB1 HDAC3 1609/4885HDAC4 825/4885HDAC1 533/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.